Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Mar 30, 2017 (Close)|
|Price (Rs)687.15||Open (Rs) 688.60||High (Rs) 694.20||Low (Rs) 685.80|
|% Change-0.21||Volume 160,141||Value (Rs) 110,528,826||52-Week H/L 854.50 / 572.40|
|Live NSE Quotes||Mar 30, 2017 (Close)|
|Price (Rs)687.05||Open (Rs) 689.80||High (Rs) 694.05||Low (Rs) 685.20|
|% Change-0.09||Volume 2,558,208||Value (Rs) 1,762,615,512||52-Week H/L 854.95 / 571.90|
|EPS (Rs)* 32.04||P/E Ratio (x) 21.45||Market Cap (Rs m) 1,653,800.32||P/BV (x) 5.27|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|Sun Pharma Share Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Indian share markets finished the trading day on a firm note as the country moved a step closer to implementing a nationwide goods and services tax (GST) from July.
Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.
Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.
Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.
Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.
Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.More Views on News
The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.
Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.
Many investors have got anchored to a selling price which has got nothing to do with the current state of the real estate market
PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.
This is why RBI's new strategy is ineffective to deal with bad debt menace.More